MDS Pharma Services is renovating and expanding its discovery pharmacology operation in Taiwan. The expansion, which will be completed in 2010, is part of the company’s new strategic focus on early stage operations, discovery through Phase IIa proof-of-concept services. The Taiwan facility supports molecular screening and profiling, as well as in vivo safety and efficacy testing. The renovation plan significantly expands and upgrades each area. In vivo capacity has been doubled and will...